Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Falk

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
The American Journal of Cardiology|February 15, 1987
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosisR H Falk, J F Plehn, T Deering, et al.
Annals of Internal Medicine|May 1, 2001
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal diseaseL M Dember, V Sanchorawala, D C Seldin, et al.
Transplantation|May 16, 1998
Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathyE A Pomfret, W D Lewis, R L Jenkins, et al.
Bone Marrow Transplantation|November 13, 2001
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosisV Sanchorawala, D G Wright, D C Seldin, et al.
Annals of Internal Medicine|January 15, 1994
Liver transplantation as a treatment for familial amyloidotic polyneuropathyM Skinner, W D Lewis, L A Jones, et al.
British Heart Journal|September 1, 1995
Is aspirin safe for patients with heart failure?J G Cleland, C J Bulpitt, R H Falk, et al.
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
The American Journal of Cardiology|February 15, 1987
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosisR H Falk, J F Plehn, T Deering, et al.
Annals of Internal Medicine|May 1, 2001
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal diseaseL M Dember, V Sanchorawala, D C Seldin, et al.
Transplantation|May 16, 1998
Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathyE A Pomfret, W D Lewis, R L Jenkins, et al.
Bone Marrow Transplantation|November 13, 2001
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosisV Sanchorawala, D G Wright, D C Seldin, et al.
Annals of Internal Medicine|January 15, 1994
Liver transplantation as a treatment for familial amyloidotic polyneuropathyM Skinner, W D Lewis, L A Jones, et al.
British Heart Journal|September 1, 1995
Is aspirin safe for patients with heart failure?J G Cleland, C J Bulpitt, R H Falk, et al.
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
Pageof 12